01/20/2026
Very excited to share our new (online ahead of print) publication in Annals of Neurology on the relative risk of deep brain stimulation surgery!
While nothing is perfect, for those of us who perform DBS, we know it is a relatively low-risk procedure, especially when compared with many other neurosurgical operations. But for patients and for clinicians without this relative frame of reference, any “brain surgery” sounds inherently dangerous.
While we can’t directly compare neurosurgical and non-neurosurgical procedures head-to-head, we tried to put DBS risk into a more familiar context. Using the database, we analyzed 2.8 million elective surgeries, including nearly 4,800 DBS cases, to compare 30-day outcomes across commonly performed elective procedures. Using this large, national dataset allowed us to take a big-data approach to perioperative risk. In general, DBS was associated with:
• Lower 30-day complication rates
• Lower reoperation rates
• Higher likelihood of discharge home
• Comparable readmission rates
Based on our analysis, procedures that are far more familiar to patients and referring clinicians (such as hysterectomy, prostatectomy, C-section, and hip replacement) were associated with a significantly higher risk than DBS surgery.
DBS remains woefully underutilized, largely because its risks are perceived rather than contextualized. The reality is that for many patients, the benefits certainly outweigh the risks.
🔗 Read the full article here: https://onlinelibrary.wiley.com/doi/10.1002/ana.78154
American Society for Stereotactic and Functional Neurosurgery
World Society for Stereotactic and Functional Neurosurgery
American Neurological Association
Jefferson Health
Vickie and Jack Farber Institute for Neuroscience Jefferson Health
Thomas Jefferson University